Form 8-K VERTEX PHARMACEUTICALS For: Oct 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Vertex (VRTX) PT Raised to $235 at RBC Capital
October 31, 2019 6:39 AM EDTRBC Capital analyst Brian Abrahams raised the price target on Vertex (NASDAQ: VRTX) to $235.00 (from $210.00) while maintaining an Outperform rating.
The analyst commented, "Overall, an in-line quarter with continued solid commercial execution on the CF franchise and pipeline remaining on track -- which despite... More
